Skip to main content
LQDA
NASDAQ Life Sciences

Liquidia Plunges 25% as Court Denies Motion to Strike in Yutrepia Patent Fight

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$53.22
Mkt Cap
$4.764B
52W Low
$21.35
52W High
$93.61
52W Position info
149% above low
Off High info
43% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

LQDA has more than doubled off its 52-week low of $21.35 on elevated volume (1.9× avg).

Summary

Liquidia shares fell 25% after Judge Richard G. Andrews denied the company's motion to strike in its patent dispute with United Therapeutics over Yutrepia. The ruling is a setback for Liquidia's defense against United Therapeutics' infringement claims, which threaten the drug's market presence. United Therapeutics rose 6.2% on the news. This follows a period of heavy insider selling at Liquidia and ongoing litigation risk disclosed in its Q2 10-Q. The next key event will be the court's substantive ruling on the patent dispute.

At the time of this announcement, LQDA was trading at $53.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.8B. The 52-week trading range was $21.35 to $93.61. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

LQDA - Latest Insights

LQDA
Nov 10, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $47.45
Real-time Price: $55.48 info
Change: +$8.03 (+17%) info
Market Cap: $5.001B info
LQDA
Nov 10, 2026, 6:45 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $47.40
Real-time Price: $55.48 info
Change: +$8.08 (+17%) info
Market Cap: $5.001B info
LQDA
Nov 10, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $50.00
Real-time Price: $55.48 info
Change: +$5.48 (+11%) info
Market Cap: $5.001B info
LQDA
Oct 13, 2026, 9:49 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $39.50
Real-time Price: $55.48 info
Change: +$15.98 (+40%) info
Market Cap: $5.001B info
LQDA
Oct 13, 2026, 5:50 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $31.76
Real-time Price: $55.48 info
Change: +$23.72 (+75%) info
Market Cap: $5.001B info